Pilar Sanjuan

Dr. Pilar Sanjuan

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Psychiatry Research
Verified
Journal Article
Closed access
PSPilar Sanjuan
Pilar Sanjuan
RTRobert Thoma
Robert Thoma
ECEric Daniel Claus
Eric Daniel Claus
NMNicci Mays
Nicci Mays
ACArvind Caprihan
Arvind Caprihan

1 December 2021 in Journal of Affective Disorders
Verified
Journal Article
Closed access
PSPilar Sanjuan
Pilar Sanjuan
KFKathryn Fokas
Kathryn Fokas
JTJ. Scott Tonigan
J. Scott Tonigan
MHMelissa C. Henry
Melissa C. Henry
KCKorinna Christian
Korinna Christian
LLLawrence Leeman
Lawrence Leeman

1 February 2019 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
PSPilar Sanjuan
Pilar Sanjuan
MPMatthew R. Pearson
Matthew R. Pearson
CPCarly Poremba
Carly Poremba
HAHortensia de Los Angeles Amaro
Hortensia de Los Angeles Amaro
LLLawrence Leeman
Lawrence Leeman

1 May 2014 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
PSPilar Sanjuan
Pilar Sanjuan
SRSamara L. Rice
Samara L. Rice
KWKatie Witkiewitz
Katie Witkiewitz
RMRaul N. Mandler
Raul N. Mandler
CCCameron Crandall
Cameron Crandall
MBMichael P. Bogenschutz
Michael P. Bogenschutz

1 March 2020 in Psychology of Addictive Behaviors
Verified
Journal Article
Closed access
PSPilar Sanjuan
Pilar Sanjuan
MPMatthew R. Pearson
Matthew R. Pearson
KFKathryn Fokas
Kathryn Fokas
LLLawrence M. Leeman
Lawrence M. Leeman
Pregnant women with substance use disorder (SUD) comprise an underserved population with complex treatment needs, including complications from trauma histories and comorbid psychological disorders. Using ecological momentary assessment, we examined momentary fluctuations in posttraumatic stress disorder (PTSD) symptoms, prenatal bonding, and substance craving, among pregnant women in SUD treatment who had a history of trauma. We hypothesized that (a) PTSD symptoms and prenatal bonding would each be associated with substance craving and (b) PTSD symptoms would be negatively associated with prenatal bonding, and this would at least partially account for the association between PTSD symptoms and substance craving (i.e., indirect effect). Participants (n = 32) were on average 27.1 weeks pregnant (SD = 5.27), 27.8 years old (SD = 4.54), and predominantly Hispanic/Latina (66%). At the within subjects level, higher momentary ratings of PTSD symptoms were associated with lower quality (but not intensity of preoccupation) of prenatal bonding, which in turn was associated with greater craving. Lower quality of prenatal bonding partially mediated the positive association between PTSD symptoms and craving, which remained strong after accounting for prenatal bonding. Our results provide some preliminary support for considering interventions aimed at stabilizing or decreasing PTSD symptoms and stabilizing or increasing prenatal bonding to reduce substance craving and, thus, the risk of perinatal substance use among women with SUD and trauma histories. (PsycINFO Database Record (c) 2020 APA, all rights reserved).

1 July 2018 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
PSPilar Sanjuan
Pilar Sanjuan
CAChloe Andrews
Chloe Andrews
ECEric D. Claus
Eric D. Claus